Half-year report · Q2
7363.TEDINET S100YNPB
Period2025-01-01 → 2025-06-30
Filed2026-06-30
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Amends S100WJ8A. Amended by S100YNPQ (2026-06-30).
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥920m | 2025-01-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥1.5bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥735m | 2024-01-01 → 2024-06-30 | Standalone | Net sales |
| Operating income | ¥100m | 2025-01-01 → 2025-06-30 | Standalone | Operating income |
| Operating income | ¥29m | 2024-01-01 → 2024-06-30 | Standalone | Operating income |
| Ordinary income | ¥96m | 2025-01-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥44m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥29m | 2024-01-01 → 2024-06-30 | Standalone | Ordinary income |
| Profit before tax | ¥96m | 2025-01-01 → 2025-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥21m | 2024-01-01 → 2024-06-30 | Standalone | Income before income taxes |
| Net income | ¥59m | 2025-01-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | −¥16m | 2024-01-01 → 2024-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥17m | 2024-01-01 → 2024-06-30 | Standalone | Profit loss |
| Total assets | ¥1.5bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥967m | at 2024-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥756m | at 2025-06-30 | Standalone | Liabilities |
| Total liabilities | ¥854m | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥734m | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥672m | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥681m | at 2024-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥431m | at 2025-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥394m | at 2024-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥431m | at 2025-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥394m | at 2024-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥350m | at 2024-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥357m | at 2023-12-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥104m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥195m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥99m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥41m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥599m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | −¥26m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥285m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥92m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥66.11 | 2025-01-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.56 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.95 | 2024-01-01 → 2024-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥65.29 | 2025-01-01 → 2025-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.64 | 2024-01-01 → 2024-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| Equity ratio | 49.0% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.0% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.5% | at 2024-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 941,700 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 941,700 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 941,700 | at 2024-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 12
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥107m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥107m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥813m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥813m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥920m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥920m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥146m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥146m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥589m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥589m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥735m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥735m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 416
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 350216000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 430976000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 394203000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 941700 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 941700 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 941700 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 941700 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 201500 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.2262 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 188500 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.2116 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 41900 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0470 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 28100 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0315 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 26300 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0295 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 21500 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0241 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 18800 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0211 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 15300 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0171 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 15000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0168 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 11968 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0134 | |
| Number of shares held | CurrentQuarterInstant | 568868 | |
| Shareholding ratio | CurrentQuarterInstant | 0.6386 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 50900 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 8892 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 889200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 1600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 941700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 8892 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 50948 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | 0 | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 50948 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0541 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 50948 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | 0 | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 50948 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0541 | |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 394203000 | JPY |
| Cash and deposits | CurrentQuarterInstant_NonConsolidatedMember | 430976000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 222446000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |